Theragen Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 106


  • Latest Deal Type
  • Debt - PPP

  • Investors
  • 1

Theragen General Information


Developer of a therapeutic technology intended for body healing and pain relief. The company's technology delivers effective and safe therapeutic energy to the body to treat pain and disease and heal tissue, enabling patients to get relief from various kinds of pain and live a healthy life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 10407 Centurion Parkway North
  • Building 400, Suite 100
  • Jacksonville, FL 32256
  • United States
+1 (888) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Theragen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Debt - PPP 15-Apr-2020 000.00 Completed Generating Revenue
1. Early Stage VC (Series A1) 21-Jun-2017 000.00 000.00 000.00 Completed Generating Revenue
To view Theragen’s complete valuation and funding history, request access »

Theragen Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Theragen’s complete cap table history, request access »

Theragen Patents

Theragen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11759637-B2 Systems, methods and devices for electrical stimulation therapy Active 05-Feb-2021 00000000000 00
US-11717685-B2 Therapeutic stimulator system Active 05-Feb-2021 00000000000 00
US-20220323754-A1 Therapeutic stimulator system Active 05-Feb-2021 00000000000
US-11426574-B1 Systems, methods and devices for electrical stimulation therapy Active 05-Feb-2021 00000000000 00
US-20220249843-A1 Therapeutic stimulator system Active 05-Feb-2021 A61N1/0464
To view Theragen’s complete patent history, request access »

Theragen Executive Team (8)

Name Title Board Seat Contact Info
Jon McAuliffe President & Chief Executive Officer
Richard Pearce Chief Operating Officer, Vice President of Research & Development
Kimball Chen Co-Founder & Chairman
Alex Evans Co-Founder & Board Member
Jan Buck Co-Founder & Board Member
You’re viewing 5 of 8 executive team members. Get the full list »

Theragen Board Members (5)

Name Representing Role Since
Alex Evans Theragen Co-Founder & Board Member 000 0000
Jan Buck Theragen Co-Founder & Board Member 000 0000
Kimball Chen Theragen Co-Founder & Chairman 000 0000
Matthew Rice Ballast Point Ventures Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Theragen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Theragen Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ballast Point Ventures Venture Capital Minority 000 0000 000000 0
To view Theragen’s complete investors history, request access »

Theragen Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000 18-Aug-2015 0000000000 Therapeutic Devices 0000 0000
To view Theragen’s complete acquisitions history, request access »